Clinical trial
Characterization of the Pharmacodynamic Response to Vaped THC
NCT04340700 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of the Pharmacodynamic Response to Vaped THC
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- November 1, 2022
- Completion date
- October 1, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
thc, vaping